Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives

Infection. 1999 Jan-Feb;27(1):1-11. doi: 10.1007/BF02565163.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies / therapeutic use
  • Antibody Specificity
  • Cytokines / immunology
  • Cytokines / physiology
  • Endotoxins / chemistry
  • Humans
  • Lipopolysaccharide Receptors / immunology
  • Lipopolysaccharide Receptors / metabolism
  • Lipopolysaccharides / metabolism
  • Lipoproteins, HDL / metabolism
  • Sepsis* / epidemiology
  • Sepsis* / etiology
  • Sepsis* / physiopathology
  • Sepsis* / therapy
  • Tumor Necrosis Factor-alpha / immunology
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • Antibodies
  • Cytokines
  • Endotoxins
  • Lipopolysaccharide Receptors
  • Lipopolysaccharides
  • Lipoproteins, HDL
  • Tumor Necrosis Factor-alpha